The best course of action for treating AD is to target both of these enzymes [6,7] by concentrating on the acetylcholinesterase enzyme, which has two binding sites: a peripheral location for the interaction of β-amyloid and a catalytic site for the hydrolysis of acetylcholine. The gene discussed is ACHE; the disease is Alzheimer disease.